News

Published on 4 Mar 2024 on Benzinga

What's Going On Avidity Biosciences Stock Today? - Avidity Biosciences (NASDAQ:RNA)

Article preview image

Monday, Avidity Biosciences Inc RNA revealed new long-term AOC 1001 data from the MARINA open-label extension (MARINA-OLE) trial showing reversal of disease progression in myotonic dystrophy type 1 (DM1) patients across multiple endpoints compared to END-DM1 natural history data. 

These are the same key endpoints used in the global Phase 3 HARBOR trial for DM1. 

Read the rest of the article
NASDAQ.RNA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, ...

Insider Monkey · via Yahoo Finance 26 Sep 2024
Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, ...

Insider Monkey · via Yahoo Finance 24 Sep 2024
Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)

Key Insights The projected fair value for Avidity Biosciences is US$46.34 based on 2 Stage Free C...

Simply Wall St. · via Yahoo Finance 20 Jun 2024
Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares

President and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the c...

GuruFocus.com via Yahoo Finance 4 Apr 2024
Insider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)

Michael Maclean, Chief Financial Officer of Avidity Biosciences Inc (NASDAQ:RNA), sold 40,000 sha...

GuruFocus.com via Yahoo Finance 15 Mar 2024
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday’s...

Shares of Bitdeer Technologies Group BTDR rose sharply during Monday’s session after the compan...

Benzinga 4 Mar 2024
What's Going On Avidity Biosciences Stock Today? - Avidity Biosciences (NASDAQ:RNA)

Monday, Avidity Biosciences Inc RNA revealed new long-term AOC 1001 data from the MARINA open-lab...

Benzinga 4 Mar 2024
Top 3 Health Care Stocks You May Want To Dump In Q1 - Avidity Biosciences (NASDAQ:RNA), Catalyst...

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to i...

Benzinga 1 Mar 2024
Avidity Biosciences secures $400 million in private placement

Avidity Biosciences, Inc. (NASDAQ: RNA), a biopharmaceutical company specializing in RNA...

Investing.com 29 Feb 2024
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates

Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.79 per share versus the Zack...

Zacks via Yahoo Finance 28 Feb 2024

Copyright Statfolio @ 2024

Social Accounts